Invention Application
- Patent Title: TREATING SICKLE CELL DISEASE WITH A PYRUVATE KINASE R ACTIVATING COMPOUND
-
Application No.: US17275741Application Date: 2019-09-19
-
Publication No.: US20220031671A1Publication Date: 2022-02-03
- Inventor: Anna ERICSSON , Neal GREEN , Gary GUSTAFSON , David R. LANCIA, Jr. , Gary MARSHALL , Lorna MITCHELL , David RICHARD , Zhongguo WANG , Sanjeev FORSYTH , Patrick F. KELLY , Madhu MONDAL , Maria RIBADENEIRA , Patricia SCHROEDER
- Applicant: FORMA Therapeutics, Inc.
- Applicant Address: US MA Watertown
- Assignee: FORMA Therapeutics, Inc.
- Current Assignee: FORMA Therapeutics, Inc.
- Current Assignee Address: US MA Watertown
- International Application: PCT/US2019/052024 WO 20190919
- Main IPC: A61K31/436
- IPC: A61K31/436 ; A61K9/00 ; A61P7/06 ; C07D491/056
Abstract:
Compounds that activate pyruvate kinase R can be used for the treatment of sickle cell disease (SCD). Methods and compositions for the treatment of SCD are provided herein, including a therapeutic compound designated as Compound 1.
Public/Granted literature
- US12053458B2 Treating sickle cell disease with a pyruvate kinase R activating compound Public/Granted day:2024-08-06
Information query
IPC分类:
